Clinical Trials in Michigan

Showing 12401-12420 of 16,154 trials

Wound Fluid Protease Levels During Use of Novel Wound Dressing

NCT01567150

This study is being conducted to characterize the way leg wounds respond to a new type of wound dressing, compared to wounds in patients who are not using the new dressing. The investigators will collect wound fluid for biochemical analysis, and they will measure the wound healing that occurs with and without the new dressing.

Venous Stasis Ulcers

Hollister Incorporated35 participantsStarted Feb 2012

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Miami, Florida, United States +5 more locations

COMPLETEDPhase 362 miles

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

NCT00113165

This study is being conducted to compare the efficacy and safety of LAMICTAL (lamotrigine) extended-release with placebo in the treatment of partial seizures. LAMICTAL extended-release is an investigational drug. Placebo tablets look like LAMICTAL extended-release tablets but do not contain active medication. In this study, LAMICTAL extended-release or placebo tablets will be added to current seizure treatments.

EpilepsyEpilepsy, Partial

GlaxoSmithKline244 participantsStarted Oct 2004

Anniston, Alabama, United States • Birmingham, Alabama, United States • Northport, Alabama, United States +145 more locations

Wound Fluid Protease Levels During Use of Novel Wound Dressing

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Find Trials by Condition in Michigan

Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)

Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

POC - Transfusion Algorithm Cardiac Study

Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)

Ticagrelor for PCI Post Thrombolysis

Confirmatory Clinical Trial of the Evera MRI System for Conditionally-safe MRI Access

Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function

Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment

A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma

Docetaxel+Oxali+/-Cetux Met Gastric/GEJ

A Trial to Compare Prophylaxis Therapy to On-demand Therapy With a New Full Length Recombinant FVIII in Patients With Severe Hemophilia A

Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)

Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography

Safety of Rt-PA + Transcranial Emission of Low-Energy Lasers for Acute Stroke Recovery

Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season

A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus